We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Interaction of Cell Surface Glycoproteins Drives Tumor Metastasis

By LabMedica International staff writers
Posted on 16 Aug 2017
Print article
Image: A photomicrograph of brain tumor section (Photo courtesy of the Brain Tumour Research Centre, University of Portsmouth).
Image: A photomicrograph of brain tumor section (Photo courtesy of the Brain Tumour Research Centre, University of Portsmouth).
Cancer researchers have shown how the interaction between two classes of cell surface glycoprotein molecules determines when a tumor will metastasize and release cells that migrate and generate secondary growths.

Cells in a low-grade tumor bind very tightly together, however the cells become less adhesive as the tumor becomes malignant. Expression of the cell adhesion molecule (CAM), Sialyl Lewis X (CD15s) correlates with cancer metastasis, while expression of E-selectin (CD62E) is stimulated by the cytokine TNF-alpha. CD15s/CD62E interaction plays a key role in the homing process of circulating leukocytes.

Investigators at the University of Portsmouth (United Kingdom) investigated the interaction of CD15s and CD62E in brain metastasis-related cancer cell adhesion. CD15s and CD62E were characterized in human brain endothelium (hCMEC/D3), primary non-small cell lung cancer (NSCLC), and metastatic NSCLC using immunocytochemistry, Western blotting, flow cytometry, and immunohistochemistry in human brain tissue sections.

They reported in the July 10, 2017, online edition of the International Journal of Molecular Sciences that CD15s was only faintly expressed on hCMEC/D3, while high levels were observed on primary NSCLC cells with expression highest on metastatic NSCLC cells. CD62E was highly expressed on hCMEC/D3 cells activated with TNF-alpha, with lower levels on primary and metastatic NSCLC cells. CD15s and CD62E were expressed on lung metastatic brain biopsies. CD15s/CD62E interaction was localized at adhesion sites of cancer cell - brain endothelium. Immune blocking of CD15s significantly decreased cancer cell adhesion to brain endothelium under static and shear stress conditions, highlighting the role of CD15s - CD62E interaction in brain metastasis.

Senior author Dr. Geoff Pilkington, head of the Brain Tumour Research Centre at the University of Portsmouth, said, "Although this work is still at an early stage, we have demonstrated key elements that are associated with tumor cell binding to blood vessels and this may provide a target for future drug development to prevent the development of secondary tumors in the brain. Increasing our understanding of the adhesive properties of tumors may also help to develop new treatments to halt the development and spread of primary brain tumors."

Related Links:
University of Portsmouth

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.